iTeos Therapeutics

Foundation date

2011

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics for patients . We leverage our deep understanding of the tumor microenvironment and immunosuppressive pathways to design novel product candidates with an aim to improve the clinical benefit of oncology therapies.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    1 day ago

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    1 day ago

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    1 day ago